|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Operating loss | |||||
| Financial expense, net | |||||
| Gain on change in fair value of Warrants liability (Note 7) | |||||
| Net loss | |||||
| Basic net loss per share (in dollars per share) | |||||
| Diluted net loss per share (in dollars per share) | |||||
| Weighted average number of shares outstanding used in computing basic net loss per share (in shares) | |||||
| Weighted average number of shares outstanding used in computing diluted net loss per share (in shares) |
Loading...
